BTK and mantle cell lymphoma: Furthermore, we found that G-1 exerted synergistic cytostatic effects with ibrutinib in MCL cells, suggesting that G-1 could be a potential candidate to combine with BTK inhibitor in chemo-free combinations for MCL.